Literature DB >> 33775721

A polymeric micellar drug delivery system developed through a design of Experiment approach improves pancreatic tumor accumulation of calcipotriol and paclitaxel.

Victor R Lincha1, Jun Zhao2, Xiaoxia Wen3, Chiyi Xiong3, Diana S-L Chow4, Chun Li5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33775721      PMCID： PMC8122084          DOI： 10.1016/j.ijpharm.2021.120523

Source DB:  PubMed          Journal:  Int J Pharm        ISSN： 0378-5173            Impact factor:   5.875


× No keyword cloud information.
  40 in total

1.  Nanoparticle-mediated cellular response is size-dependent.

Authors:  Wen Jiang; Betty Y S Kim; James T Rutka; Warren C W Chan
Journal:  Nat Nanotechnol       Date:  2008-03-02       Impact factor: 39.213

2.  Modulation of Pharmacokinetic and Cytotoxicity Profile of Imatinib Base by Employing Optimized Nanostructured Lipid Carriers.

Authors:  Biki Gupta; Bijay Kumar Poudel; Tuan Hiep Tran; Roshan Pradhan; Hyuk-Jun Cho; Jee-Heon Jeong; Beom Soo Shin; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Pharm Res       Date:  2015-05-05       Impact factor: 4.200

Review 3.  Targeting nanoparticles to cancer.

Authors:  M Wang; M Thanou
Journal:  Pharmacol Res       Date:  2010-04-07       Impact factor: 7.658

Review 4.  Liposomes revisited.

Authors:  D D Lasic; D Papahadjopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

5.  Size-Dependent Endocytosis of Nanoparticles.

Authors:  Sulin Zhang; Ju Li; George Lykotrafitis; Gang Bao; Subra Suresh
Journal:  Adv Mater       Date:  2009       Impact factor: 30.849

6.  Acrylic microspheres in vivo IX: Blood elimination kinetics and organ distribution of microparticles with different surface characteristics.

Authors:  P Arturson; T Laakso; P Edman
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

7.  Size control in production and freeze-drying of poly-ε-caprolactone nanoparticles.

Authors:  Tereza Zelenková; Davide Fissore; Daniele L Marchisio; Antonello A Barresi
Journal:  J Pharm Sci       Date:  2014-04-15       Impact factor: 3.534

8.  Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy.

Authors:  Jun Zhao; Huamin Wang; Cheng-Hui Hsiao; Diana S-L Chow; Eugene J Koay; Yaan Kang; Xiaoxia Wen; Qian Huang; Ying Ma; James A Bankson; Stephen E Ullrich; Willem Overwijk; Anirban Maitra; David Piwnica-Worms; Jason B Fleming; Chun Li
Journal:  Biomaterials       Date:  2018-01-09       Impact factor: 12.479

9.  Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.

Authors:  R Alvarez; M Musteanu; E Garcia-Garcia; P P Lopez-Casas; D Megias; C Guerra; M Muñoz; Y Quijano; A Cubillo; J Rodriguez-Pascual; C Plaza; E de Vicente; S Prados; S Tabernero; M Barbacid; F Lopez-Rios; M Hidalgo
Journal:  Br J Cancer       Date:  2013-08-01       Impact factor: 7.640

10.  Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years.

Authors:  Bradley R Hall; Andrew Cannon; Pranita Atri; Christopher S Wichman; Lynette M Smith; Apar K Ganti; Chandrakanth Are; Aaron R Sasson; Sushil Kumar; Surinder K Batra
Journal:  Oncotarget       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.